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SummAry
The aim of Health Technology Assessment (hTA) is to provide decision-makers, distributors and recipients with information on the 
effectiveness, cost and impact of health technologies. The present study constitutes a subproject within the wider project “Analysis of 
the impact of professional involvement in evidence generation for the hTA process”, which is part of the strategic programme “Trans-
fer of the results of the research in clinical practice and organisation of healthcare services”, coordinated by laziosanità – Agency of 
Public healthcare of the lazio region and AgenaS (national Agency for regional healthcare Services). The objectives of the present 
subproject (cochlear implants) are as follows: a) to produce a report regarding the health impact of cochlear implants (Ci) on their re-
cipients, through a systematic review of literature and extensive selection of relative studies, combining the outcomes with metanalytical 
techniques. output: report on the indications of usage in the groups of population for which benefits are controversial; b) to create a 
registry of patients using cochlear implants. The registry should contain a selection of anagraphic and clinical information relative to 
patient follow-up in order to assess factors associated with safety and impact on cochlear implant users. This source of information is 
essential for future observational studies. This was divided into 4 phases: 1st phase: definition of key participants in the assessment proc-
ess; 2nd phase: definition of methods and timing of “Aims” (definition of the objective); 3rd phase: definition of the methods and times of 
the “assessment process”, 4th phase: production of the final report. From the analysis of systematic reviews and italian and international 
guidelines, the Working group members approved recommendations on the following topics: results after Ci in children in relation to 
age at implantation, bilateral Ci in children, Ci in deaf children with associated disabilities, Ci in adults with advanced age, bilateral 
Ci in adults and Ci in adults with pre-lingual deafness. These recommendations have also been evaluated by the Consulting Committee 
members and approved with minimal suggestions.
Key WordS: Cochlear implant • Health Tecnology Assessment • Clinical effectiveness • Cost-effectiveness • Registry
riASSunTo
L’Health Technology Assessment (HTA) nasce per fornire a chi pianifica, eroga e riceve prestazioni sanitarie informazioni sull’effica-
cia, costi e impatto delle tecnologie sanitarie. Il presente studio costituisce un sottoprogetto nell’ambito del progetto “Analysis of the 
impact of professional involvement in evidence generation for the HTA process” parte del programma strategico dal titolo “Trasferi-
mento dei risultati della ricerca nella pratica clinica e nella organizzazione dei servizi sanitari”, coordinato da Laziosanità – Agenzia 
di Sanità Pubblica della Regione Lazio e AgeNaS (Agenzia Nazionale per i Servizi Sanitari Regionali). Gli obiettivi proposti per il 
presente sottoprogetto sono stati articolati in due punti: a) produrre un report sull’impatto sulla salute dei pazienti portatori di im-
pianto cocleare (IC), mediante una revisione sistematica della letteratura e, dopo attenta selezione degli studi, combinando i risultati 
con tecniche meta-analitiche. Output: report sulle indicazioni di utilizzo in gruppi di popolazione per cui i benefici sono controversi; 
b) impostare un registro di pazienti portatori di IC. Il registro dovrebbe contenere una selezione delle informazioni anagrafiche, clini-
che e relative al follow-up dei pazienti al fine di valutare possibili determinanti associati con la sicurezza e l’impatto sulla salute dei S. Berrettini et al.
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pazienti portatori di IC. Questo costituirebbe una fonte di informazioni indispensabili per successivi studi osservazionali. Il lavoro è 
stato svolto in 4 fasi: 1a fase: definizione partecipanti chiave nel processo di valutazione; 2a fase: definizione metodi e i tempi dello 
scoping (definizione dell’obiettivo); 3a fase: definzione metodi e tempi dell”assessment process” (processo di valutazione); 4a fase: 
produzione del report finale. Dall’analisi dei risultati delle reviews sistematiche e delle principali linee guida nazionali e internazio-
nali, i membri del Gruppo di Lavoro, hanno elaborato i criteri di appropriatezza della procedura in oggetto per le seguenti categorie 
di pazienti: risultati post-IC nei bambini in relazione alla precocità dell’impianto, IC bilaterale nei bambini, IC in bambini sordi con 
disabilità associate alla sordità, IC in pazienti adulti con età avanzata, IC bilaterale nei pazienti adulti, IC bilaterale nei pazienti 
adulti con sordità pre-verbale. Queste raccomandazioni sono state valutate anche dai componenti del Consulting Commettee e appro-
vate con minimi suggerimenti. 
PArole ChiAve: Impianto cocleare • Health Tecnology Assessment • Efficacia clinica • Costo-efficacia • Registro
Acta Otorhinolaryngol Ital 2011;31:273-280
Introduction
Why a report on Health Technology Assessment?
over the last decades, the continuous growth of medical 
technology in the healthcare system has led to an unlimit-
ed expansion of services, but at the same time has made it 
clear that the amount of resources that the national health 
Service can offer to its patients is limited 1. Therefore, 
health policy decisions are becoming increasingly impor-
tant, and it seems necessary to consider carefully invest-
ment choices that can be can afforded and worth making. 
For this reason, decision-makers within the public health 
system should be provided with specific tools to assess 
the validity, effectiveness, safety and cost efficacy of the 
different healthcare improvements suggested in order to 
decide whether they are worth adopting.
The aim of Health Technology Assessment (hTA) is to 
provide decision-makers, distributors and recipients with 
information on the effectiveness, cost and impact of health 
technologies 2-5.
An hTA review should have solid scientific foundations 
that support its conclusions, but should also be simple and 
easily understood by decision-makers who are not experts 
in the field. For these reasons, the report includes an “ex-
ecutive summary”, written in simple, non-technical lan-
guage, and a “full report” containing various chapters and 
appendices with all the scientific information conveyed in 
the executive summary. The discussion, conclusions and 
recommendations of the present article reflect those re-
ported in the executive summary of the report on the web 
site  https://sites.google.com/site/impianticoclearipisa/, 
and will be soon inserted in the Age.na.S website (www.
agenas.it/).
Within the italian health System, many of the decisions 
as to what should be considered an essential level of As-
sistance are made by on a regional level. unfortunately, 
this often leads to overlap and redundancy; at the same 
time, individual regions often lack sufficient resources to 
ensure assessment of all new technologies. For these rea-
sons, regions have started to organize themselves in a na-
tional network coordinating the hTA activities, aimed at 
reducing waste and duplication of labour, while respect-
ing the autonomy of each region. Age.na.S. (national 
Agency  for  regional  healthcare  Services)  coordinates 
this network, which is now called the italian network of 
hTA, rihTA (rete italiana hTA). At the onset of this 
process, the Tuscany region submitted the following cru-
cial questions to the newly-formed Coordinating group: 
who should be guaranteed a cochlear implant? Where is it 
possible to find the best cost-effective benefits? The pro-
posal, which falls within a larger development project of 
hTA in italian regions, has resulted in the publication of 
this project.
As the reader may observe, the Working group (Wg) en-
gaged in the drafting of the report took into account all the 
above-mentioned issues concerning cochlear implants in 
both children and adults, through careful analysis not only 
of the most significant literature in the field, but also us-
ing less conventional information sources, with particular 
regard to organisational, ethical and social implications. it 
determined the most critical areas in which scientific evi-
dence was still weak, and it recommended methods which 
could help current clinical practice to produce evidence 
through the creation of registries.
The Wg has provided recommendations for better and 
more correct organizational modes for intervention. Fi-
nally, it indicates effectiveness and cost efficacy. hTA is a 
process of assessment according to which technicians and 
specialists cannot work isolated from society and citizens 
who will be benefit from the technology under scrutiny. 
This request will not only be represented by the politi-
cal power elected, which in any case has full decisional 
independence after having been informed by the report, 
but should also be represented by active interlocutors in 
some of the crucial phases of the assessment process. For 
this reason, the Wg involved all stakeholders, i.e. patient 
associations, device manufacturers and scientific societies 
from the earliest phases of definition of the aims of the re-
port, submitting a detailed list of questions to be answered 
and asking whether they were exhaustive, pertinent and 
correctly posed.
This study constitutes a subproject within the broader proj-
ect “Analysis of the impact of professional involvement in hTA cochlear implants: methodology, results and recommendations
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evidence generation for the hTA process”, which is part 
of the strategic programme “Transfer of the results of the 
research in clinical practice and organisation of healthcare 
services”. The project was coordinated by laziosanità - 
Agency of Public healthcare of the lazio region, while 
the strategic programme was coordinated by Age.na.S.
The principle aim of the project, which is part of the 
strategic programme to assess the involvement of the 
specialists of national Sanitary System (nSS), is the 
production of scientific evidence. Within the framework 
of the project “Analysis of the impact of professional in-
volvement in evidence generation for the hTA process”, 
the  Tuscany  region  proposed  the  Cochlear  implants 
Technique, with the priority to clearly identify criteria 
for reimbursement by the national health Service. The 
methodology employed for the hTA report was tailored 
to the needs of the italian situation starting with the indi-
cations contained in the “guide to Technology Appraisal 
Process” of the uK national institute for Clinical excel-
lence (niCe) 6.
The  objectives  of  the  present  subproject  (cochlear  im-
plants) are as follows:
a) To produce a report concerning the health impact on 
cochlear implant recipients, through a systematic re-
view of literature and extensive selection of relevant 
studies,  combining  outcomes  with  metanalytical 
techniques. output: report on the indications of us-
age in the patient groups for which benefits are con-
troversial.
b) To create a registry of patients using cochlear im-
plants.  The  registry  should  contain  a  selection  of 
anagraphic and clinical information that is relative 
to patient follow-up to assess factors associated with 
safety and impact on cochlear implant users. This 
source of information is essential for future observa-
tional studies.
The Wg of the present project, after discussion and con-
sensus,  assumed  that  Ci  is  a  well  established  clinical 
treatment for specific patient groups. These include adults 
with severe to profound sensorineural hearing loss, chil-
dren under two years of age with profound sensorineural 
hearing loss and children between 2 and 18 years of age 
with severe to profound sensorineural hearing loss 7-9. As 
a consequence, the Wg decided to focus on the following 
controversial and emergent Ci issues.
Objective a1) With regard to the assessment of clinical 
effectiveness of CI procedure in children, we analyzed the 
following topics: post-implant outcome in relation to early 
implantation; bilateral cochlear implantation (simultane-
ous/sequential) vs. unilateral Ci and vs. bimodal stimula-
tion; benefits from cochlear implantation in children with 
multiple disabilities.
With regard to the assessment of clinical effectiveness of 
CI procedure in adults, we analyzed the following topics: 
unilateral Ci in the elderly; bilateral cochlear implanta-
tion  (simultaneous/sequential)  vs.  unilateral  Ci  and  vs. 
bimodal stimulation; benefits from unilateral Ci in pre-
lingual deafened adults.
Objective a2) The systematic economic review evaluated 
the cost effectiveness of CI in children and adults. The 
review included primary studies of economic evaluation 
(analyses of cost, cost effectiveness, cost utility and cost 
benefit). With regard to children, the following categories 
have been analyzed: unilateral Ci; bilateral simultaneous 
Ci and bilateral sequential Ci.
in adults, the following categories have been analyzed: 
unilateral Ci, unilateral Ci in the elderly, unilateral Ci in 
pre-lingual deafened adults and bilateral cochlear implan-
tation (simultaneous/sequential).
Objective b) A model of Ci recipient registry derived 
from the consensus of the Wg members is proposed, 
collecting  demographic  data,  clinical  and  audiologi-
cal data, surgical data, device data, rehabilitative and 
follow-up data. The full-length of the report is on the 
web  site  https://sites.google.com/site/impianticoclear-
ipisa/ and will soon be inserted on the Age.na.S website 
(www.agenas.it/).
Methodology
The work was divided into 4 phases:
1st phase: definition of key participants in the assessment 
process
A Working group (Wg) was set up in the early phase 
of this work – June 2009. The creation of the Wg, and 
in particular the choice of members and recruitment, was 
carried out by the Scientific Coordinator of the subproject 
(Prof. Stefano Berrettini). All candidates in the Wg were 
invited to participate by the Tuscany region, specifying 
the aims of the project and methodology to be followed.
The Wg was formed of italian researchers and clinicians 
from both hospital divisions and university structures 
with experience in the field of cochlear implants, con-
firmed by extensive case studies of both adult and pae-
diatric patients, as well as scientific production. All the 
members of the Committee responsible for laying down 
the guidelines for cochlear implantation for the italian So-
ciety of otorhinolaryngology were included in the Wg 7. 
experts in healthcare organization, economy and epide-
miology were also included. The members of the Wg are 
reported in Table i.
The  Consulting  Committee  (CC)  (which  includes  all 
“Stakeholders”) was established. The creation of the CC, 
and in particular the choice of members and their recruit-
ment, was the responsibility of the Scientific Coordinator 
of the subproject (Prof. Stefano Berrettini), in agreement 
with the members of the Wg and in collaboration with the 
Tuscany region. The member candidates were invited to 
participate in the CC. The Scientific Coordinator invited S. Berrettini et al.
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the members of the CC to participate in the project after 
explaining the aims and role of stakeholders. The mem-
bers of the CC are listed in Table ii.
in September 2009, the Wg appointed Prof. Berrettini, 
Prof. Turchetti and dr. Forli to proceed with the project 
and compile the final report. in particular, Prof. Berrettini 
and dr. Forli were entrusted with the elaboration of the 
project and final version of the report relative to clinical 
effectiveness of the cochlear implant procedure in adults 
and children, while Prof. Turchetti was assigned the re-
port on cost-efficacy. Prof. Berrettini and dr. Forli were 
also appointed to proceed with the implementation of a 
registry to collect data on implanted patients.
2nd phase: definition of methods and times of “Aims” (def-
inition of the objective)
The creation of the Wg and CC was followed by the defi-
nition of the objectives (Aims). This document was ap-
proved by members of the Wg during the first meeting 
and successively sent via email and approved by members 
of the CC.
The aims of the subproject on Cochlear implants in the 
document on Aims (october 2009) is reported in the in-
troduction section.
during the meeting on 30 January 2010, the members of 
the Wg, given the uniform evidence of national and in-
ternational literature and having studied the main inter-
national guidelines concerning the procedure in question, 
considered as universally accepted the usefulness/effec-
tiveness of the unilateral Ci procedure in severe/profound 
deaf adults and children, and to focus the systematic re-
views on clinical effectiveness and cost-efficacy of the co-
chlear implant procedure on more controversial issues for 
which international consensus is lacking.
Furthermore, after a first qualitative analysis of the litera-
ture on the Ci procedure in adult and paediatric patients 
and a study of the main international guidelines on this 
procedure, the Wg reformulated the objectives of system-
atic reviews on the clinical effectiveness and cost efficacy 
of the Ci.
Therefore, the definite objectives faced by the systematic 
reviews were the following:
Table I. Members of the Working Group of the subproject*.
Prof. Edoardo Arslan, Chair of Audiology and Phoniatrics, University of Padua.
Prof. Angelo Baggiani**, Associate Professor of General and Applied Hygiene, Department of Experimental Pathology, Medical Biotechnologies, 
Infectivology and Epidemiology, University of Pisa.
Dr. Sandro Burdo, Director of the Operative Unit of Audiovestibology of the Hospital of the Circolo di Varese.
Dr. Domenico Cuda, Director of the Operative Unit, ORL Hospital “G. Saliceto”, Piacenza.
Prof. Ettore Cassandro, Director of the Audiology and Phoniatrics Unit, University of “Magna Graecia”, Catanzaro, Italy.
Prof. Roberto Filipo***, Director of the Clinic for Otorhinolaryngology and sensory and motory rehabilitation and communication disturbances, Sapienza 
University of Rome.
Dr. Francesca Forli, Researcher Operative Unit of Otorhinolaryngology, Audiology and Phoniatrics, University of Pisa.
Prof. Alessandro Martini, Director Operative Unit, ORL Otosurgery, University of Padua.
Prof. Antonio Quaranta, Director of the Otorhinolaryngology Clinic “G. Lugli”, University of Bari, Otological and Otoneurological Microsurgery.
Prof. Nicola Quaranta, Associate Professor of Otolaryngology, Otorhinolaryngology Clinic “G. Lugli”, University of Bari, Otological and Otoneurological 
Microsurgery
Prof. Giuseppe Turchetti****, Institute of Management, Scuola Superiore “Sant’Anna”, Pisa.
* Prof. Stefano Berrettini appointed Dr. Elisa Dinelli (physician of ORL, Operative Unit of Otorhinolaryngology, Audiology and Phoniatrics, University of Pisa); ** Prof. Angelo 
Baggiani appointed Dr. Mario Miccoli (Department of Experimental Pathology, Medical Biotechnologies, Infectivology and Epidemiology, University of Pisa), expert in medical 
statistics; *** Prof. Roberto Filippo appointed Dr. Patrizia Mancini (Researcher at the Clinic of Otorhinolaryngology and sensory and motory rehabilitation and communication 
disturbances, Sapienza University of Rome); **** Prof. G. Turchetti appointed Dr. Ilaria Palla (Institute of Management, Scuola Superiore “Sant’Anna”, Pisa), and Dr. Stefania Bellelli 
(Institute of Management, Scuola Superiore “Sant’Anna”, Pisa).
Table II. Members of the CC.
Delegate of the President of the Italian Society of Otorhinolaryngology and Cervico Facial Surgery (SIO), Prof. Giovanni Carlo Modugno
President of FIADDA (Famiglie Italiane Associate Difesa Diritti Audiolesi: Italian Association of Families Defending the Rights of Hearing Impaired Patients), 
Dr. Silvana Baroni
Delegate of the President of ENS (Ente Nazionale Sordomuti: Deaf National Association), Dr. C. Caselli
President of the Italian Society of Audiology and Phoniatrics, Prof. Alessandro Martini (in office since 2009)
President of ASIC (Associazione per la Sordità e Impianti Cocleari: Association for Deafness and Cochlear Implants), Dr. Antonino Morabito
Delegate of the President of Assobiomedica*, Dr. Davide Perego, Responsible for the Area “Scienza & Tecnologia Centro Studi Assobiomedica”
* Assobiomedica is involved as representative of the 4 Cochlear Implant Manufacturing Companies.hTA cochlear implants: methodology, results and recommendations
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Aim a1) clinical effectiveness of the cochlear implant pro-
cedure in the adult and child
Children: 1) post-Ci results with respect to Ci precocity; 
2) bilateral (simultaneous/sequential) Ci versus unilateral 
Ci and versus bimodal stimulation; benefits resulting from 
the Ci procedure in children with deafness-associated dis-
abilities.
Adult  patients:  1)  monolateral  Ci  in  elderly  patients; 
2) bilateral (sequential-simultaneous) Ci versus unilateral 
Ci and versus bimodal stimulation; 3) benefits resulting 
from monolateral Ci procedure in prelingual deaf adult 
patients.
Aim a2) cost-efficacy of the cochlear implant procedure in 
adults and children
Children: 1) monolateral cochlear implants in paediatric 
age; 2) simultaneous bilateral cochlear implants in paedi-
atric age; 3) sequential bilateral cochlear implant in pae-
diatric age.
Adult patients: 1) monolateral cochlear implants in adult 
patients; 2) monolateral cochlear implants in advanced-
age adult patients; 3) monolateral cochlear implants in 
prelingual adult patients; 4) bilateral (sequential or simul-
taneous) cochlear implants in adult patients.
3rd phase: definition of the methods and times of the “as-
sessment process”
The third phase of the project consisted in a systematic 
review of the literature regarding aims a1), a2) and formu-
lation of a registry proposal of cochlear implant users b).
Both the partial and definite results deriving from the 
systematic  reviews  (aims  a1  and  a2)  were  submitted 
to, discussed and approved by the members of the Wg 
during the meeting. on the basis of the data obtained 
from the reviews, the members of the Wg decided not 
to carry out a meta-analysis, owing to the heterogeneous 
outcomes.
According to the evidence resulting from a systematic 
analysis of the literature, the appropriateness of the pro-
cedure was identified. A registry proposal to be used with 
cochlear implant recipients was also developed. The fi-
nal text of the report (containing some suggestions of the 
CC members) was approved by all members of the Wg 
(may 2011).
4th phase: production of the final report
The fourth phase of the project consisted in drafting 
the final report. The text of the final report was submit-
ted via email to all the members of the Wg who ap-
proved it unanimously (march 2011). Successively, the 
text of the final report was submitted to the attention 
of the members of the CC (April 2011). The final text 
of the report (which contains some recommendations 
by the CC) was approved by all members of the Wg in 
may 2011.
Results
Clinical effectiveness. Systematic review
electronic databases were searched for relevant published 
literature on the clinical effectiveness of cochlear implants 
in adults and children. initial searches were undertaken in 
2009 and updated in an advanced phase to 31st may 2010. 
The methodology is fully explained in the reports. A nar-
rative review was undertaken and no meta-analyses of the 
clinical data were conducted, as the data were too hetero-
geneous for pooling.
The systematic search for clinical effectiveness in children 
produced 929 abstracts/titles. From the search results, 791 
items were excluded on the basis of title and abstract. 138 
papers were evaluated (full text copy), and 49 were in-
cluded in the clinical effectiveness review.
The systematic search for clinical effectiveness in adult 
patients produced 981 abstracts/titles. From the search 
results, 894 items were excluded on the basis of title and 
abstract. 87 papers were evaluated (full text copy), and 24 
were included in the clinical effectiveness review.
Children
With regard to the results after cochlear implantation in re-
lation to early implantation, only a few studies have com-
pared the results of children implanted in the first year of 
life with those implanted in the second year of life. Better 
linguistic results are reported in children implanted before 
12 months of life, even if no sufficient data exist regarding 
the relation between this advantage and the duration of 
implant use and how long the advantage persists in subse-
quent years. moreover, the sample sizes are small and not 
all studies report statistically significant results.
With regard to the CI in children older than 12 months, the 
selected studies show better hearing and linguistic results 
in children implanted at earlier ages. nevertheless, the sam-
ples are heterogeneous with regard to the age at implanta-
tion and the analyzed outcome, and not all studies report 
statistical significance. nonetheless, a sensitive period un-
der 24-36 months has been identified over which cochlear 
implantation is reported to be less effective in terms of im-
provements in speech and hearing.
With regard to clinical effectiveness of bilateral CI, the 
included studies report greater benefits from bilateral im-
plants compared to monolateral implants when assessing 
hearing in quiet environments, and overall in noise and 
sound  localization  abilities.  Benefits  are  reported  to  be 
present for simultaneous or sequential bilateral implanta-
tion. however, with regard to the delay between surgeries 
in sequential bilateral implantation, although benefit is re-
ported to be present even after very long delays, on average 
a long delay between surgeries seems to negatively affect 
outcome with the second implant. none of the studies re-
port on the impact of bilateral Ci on linguistic skills and 
cognitive abilities.S. Berrettini et al.
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The results of the few studies comparing bilateral implan-
tation to bimodal stimulation are too heterogeneous to 
draw even descriptive conclusions.
With regard to benefits after CI in children with multiple 
disabilities, the included studies report benefits in terms 
of speech perception and communication as well as in 
quality of daily life. generally, the benefits are slower and 
lower in comparison to those usually attained by implant-
ed children without additional disabilities.
Adult patients
With regard to benefits after CI in the elderly, good post-
operative perceptive results and improvements in quality 
of life are reported in elderly patients.
With regard to clinical effectiveness of bilateral CI, the 
included studies report benefits from bilateral Ci in hear-
ing in noise, in quiet and in sound localization abilities, 
in comparison to unilateral Ci. Benefits are reported in 
patients simultaneously or sequentially implanted.
With regard to benefits after CI in prelingual deafened 
adults, a few studies have been selected, due to the het-
erogeneity of the reported samples. Benefits are reported 
in terms of speech perception and quality of life even if 
with widely variable results.
Cost effectiveness. Systematic review
Published studies in english language were searched us-
ing the following electronic databases: Pubmed med-
line, Cochrane Controlled Trials register and Cochrane 
Systematic  reviews  database  and  Centre  for  reviews 
and  dissemination  (Crd)  which  includes  database  of 
Abstracts of review of effects (dAre), nhS economic 
evaluation  database  (nhS  eed)  and  hTA  database. 
The search was performed for the period 2000-September 
2009 and updated to 31 may 2010. The methodology is 
fully described in the individual reports.
Children
68 articles were extracted by the search procedure. The 
reviewers  eliminated  54  articles  that  did  not  meet  the 
inclusion criteria. After reading the abstract, 11 articles 
were retrieved and assessed for eligibility. The reviewers 
manually added 5 articles identified from bibliography 
research. on reading the full text copies, 9 publications 
were considered relevant to the review.
The review reports the results in terms of cost analysis, 
cost effectiveness and educational costs. The studies in-
cluded had different characteristics in terms of nature, 
design and methodology of analysis: 7 studies were con-
ducted in europe (5 in uK, 1 in germany and 1 in France), 
1 in uSA and 1 in Canada. Two studies were multicentre 
and 4 single centre. Three studies were prospective, 3 ret-
rospective and 3 cross-sectional. Five studies presented 
partial economic evaluation (cost analysis). Four studies 
presented complete economic evaluation: 2 cost utility 
analyses, 1 cost benefit analysis and 1 cost effectiveness 
analysis.
The articles related to cost analysis considered the direct 
and/or indirect costs of Ci. only two publications report 
both categories of costs. one paper discusses in detail 
the direct and indirect costs and the relative methodology 
used. The other reports the costs in an aggregate form. 
The direct costs ranged from € 39,172 to € 69,297
 a. The 
main cost items were pre-operative costs, operative costs 
and post-operative costs.
The studies that performed a cost effectiveness analysis 
were different: one publication described a cost utility 
analysis  as  related  to  the  instrument  utilized  (cost  per 
QAly ranges between € 4720 and € 8200); another re-
ported cost per QAly ranging from € 1998 to € 15,359; an 
uK study claimed that the benefits in terms of health util-
ity are significant and sufficiently large to justify costs.
The systematic review includes the analysis of education-
al costs as these are very significant from an economic 
point of view: the costs increase according to the level of 
hearing loss and the type of school attended.
Ci in children opens important debates from economic, 
clinical and ethical points of view. A relevant limit in the 
economic review is the paucity of published studies. Ci is 
expensive, in particular because of the cost of the device 
and lifelong support. if healthcare costs are high, the sav-
ings in terms of indirect costs and quality of life are also 
important. Ci, in fact, has a positive impact in terms of 
quality of life and is strongly recommended for children 
before two years of age.
Adults
64 publications were identified, and according to inclusion 
and exclusion criteria 57 studies were excluded, leaving 7 
eligible articles for the systematic review on the economic 
aspects for cochlear implants in adults. From the references 
of the selected articles, 1 additional study was considered 
eligible for a total of 8 eligible publications. Four studies 
were excluded, and at the end of the inclusion-exclusion 
process 4 articles were selected to assess costs and ben-
efits of cochlear implantation in adults. Three studies were 
conducted in europe (2 in uK and 1 in France) and 1 in 
uSA; 3 studies were multicentre and 1 was monocentric; 2 
studies were prospective and 2 were retrospective; 1 study 
presented a partial economic evaluation (cost analysis) and 
3 presented a cost utility analysis; 3 studies used the health-
care system perspective for cost analysis and 1 study did 
not specify the perspective. All 4 studies analyzed unilat-
eral cochlear implants, and 1 of the 4 studies also exam-
a To facilitate comparison of cost analysis with the studies included in the review, costs were converted in Euro – 2009. Costs in national currencies have been inflated to 2009 
and currencies different from Euro were converted in Euro.hTA cochlear implants: methodology, results and recommendations
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ined bilateral Ci. All 4 studies included patients with post-
lingual deafness, and 1 also examined a small group of six 
pre-lingual deaf adults.
The systematic review of the economic literature sug-
gested that monolateral cochlear implants are cost ef-
fective in adults. The monolateral Ci has a cost/QAly 
ranging from € 24,000/QAly to € 32,000/QAly com-
pared to no intervention for patients with post-lingual 
deafness. Few economic studies were available, and fu-
ture research is recommended to provide further insights 
on the cost effectiveness of monolateral and bilateral 
cochlear implants.
Discussion
This is one of the first hTA reports on a complex medi-
cal device/surgical intervention in italy by governmental 
agencies and universities 10. We can use this experience as 
a case study to better understand barriers and opportuni-
ties for hTA in italy.
The production of the report did not face substantial bar-
riers, and the Wg easily agreed on the criteria for system-
atic review and literature analysis. The Wg included most 
of the centres performing Ci in italy, comprising both 
research centres (university hospitals and irCCS) and 
non-research hospitals. Scientific societies had a determi-
nant role in maintaining a balance in the different points 
of view (clinicians and economists) and the recruiting of 
experts from different centres.
Finally, the CC participated actively and constructively, 
and the external review was performed without problems. 
in particular, the participation of stakeholders, both manu-
facturers and patients associations, was successful and al-
lowed meaningful assessment of ethical and social issues, 
which are usually neglected in most hTA reports 11. We 
hope that such a collaborative process will make the re-
port acceptable by all interested parties, and consequently 
a useful tool for decision making.
With regard to the second aim of the project, namely the 
proposal of a registry for cochlear implant recipients, is 
one of the first efforts in italy in this field. All members of 
the Wg actively participated in the creation of a registry 
that was approved, with minimal suggestions by the mem-
bers of the CC. We hope that, if adopted by Ci teams, it 
will be useful for future observational studies.
Conclusions and recommendations
The following recommendations derive from analysis of 
the results of systematic reviews and italian and interna-
tional guidelines. They were approved by the Wg mem-
bers after several meetings. They were also approved with 
minimal suggestions by CC members. Some of the obser-
vations suggested by the CC were approved by all Wg 
members.
1. Children under 2 years of age
Ci is indicated when all the three below criteria are satis-
fied:
•  Age: ≥ 12 months. The actual level of evidence does 
not justify systematic implantation in the first year of 
life. This indication should be limited to cochlear os-
sification or to selected cases reliably evaluated by ex-
perienced teams, with a defined diagnosis with regards 
to hearing threshold, aetiology and site of lesion.
•  Hearing threshold level: CI is indicated in children with 
bilateral profound deafness (mean threshold between 
0.5-1-2 kHz ≥ 90 dB HL), detected with both subjective 
and objective methods.
•  Results with hearing aids: no significant communica-
tive  and  hearing  improvement  after  a  period  of  3-6 
months with hearing aids and speech therapy training 
(except in the case of documented incipient cochlear 
ossification).
2. Children between 2 and 18 years of age
Ci is indicated when all three of the following criteria are 
satisfied:
•  Hearing threshold level: CI is indicated in children with 
bilateral severe to profound hearing loss (mean threshold 
between 0.5-1-2 khz > 75 dB hl) detected with both 
subjective and objective methods.
•  Results with hearing aids: no significant b communicative 
and hearing improvement after a period of 3-6 months 
with hearing aids and speech therapy training (except in 
the case of documented incipient cochlear ossification).
•  Speech perception abilities: evaluation of speech percep-
tion abilities is recommended using materials appropri-
ate to age and speech development. Ci is indicated if the 
open-set speech recognition score is ≤ 50% in the best 
aided condition without lip reading. in selected cases, 
Ci is indicated if the open-set speech recognition score 
is ≤ 50% in the best aided condition without lip reading 
with background noise (signal to noise ratio Snr+10).
3. Deaf children with associated disabilities
Ci in children with multiple disabilities is indicated. in-
dications and prognosis should be considered on a case-
by-case  basis.  Comprehensive  counseling  with  family 
members and caregivers is mandatory. The benefits after 
implantation should be expected both in terms of speech 
and language improvement and quality of life.
4. Adult patients (post-verbal deafness)
Ci is indicated in adult patients with bilateral severe to 
profound  hearing  loss  (mean  threshold  between  0.5-
b Speech, language and listening skills appropriate to age, developmental stage and cognitive ability.S. Berrettini et al.
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1-2  khz  >  75  dB  hl),  with  open-set  speech  recogni-
tion score ≤ 50% in the best aided condition without lip 
reading. in selected cases, Ci is indicated if the open-set 
speech recognition score is ≤ 50% in the best aided condi-
tion without lip reading with background noise (signal to 
noise ratio Snr + 10).
Ci is admitted in selected cases with better residual hear-
ing at low and middle frequencies and hearing threshold 
between 2 and 4 kHz ≥ 90 dB, with an open-set speech 
recognition score ≤ 50% in the best aided condition with-
out lip reading.
5. CI in the elderly
Ci in the elderly is admitted, without any upper limit of 
age. general health problems and life expectancy should 
be taken into account, and Ci indications should be con-
sidered on a case-by-case basis.
6. Adults with pre-verbal deafness
indications for Ci and prognostic factors should be ana-
lyzed on a case-by-case basis. Factors to be taken into ac-
count mainly include progression of deafness, hearing aid 
use and rehabilitation (in particular methodology of reha-
bilitation), results with hearing aids, patient motivations 
and psychological aspects.
7. Bilateral CI is indicated in the following conditions
a. Adult patients:
•  patients with deafness and initial bilateral cochlear 
ossification (ex postmeningitic);
•  deaf-blind patients or patients with multiple disabili-
ties (that increase their reliance on auditory stimuli 
as a primary sensory mechanism for spatial aware-
ness);
•  unsatisfactory results with unilateral CI if better re-
sults are achievable with a contralateral Ci;
•  patients with CI failure if reimplantation in the same 
ear is contraindicated.
b. Children:
•  children with bilateral profound sensorineural hear-
ing  loss,  who  cannot  achieve  significant  benefits 
with bimodal hearing;
•  children with postmeningitic deafness and initial bi-
lateral cochlear ossification (ex postmeningitic);
•  deaf-blind children;
•  unsatisfactory results with unilateral CI, if better re-
sults are achievable with a contralateral Ci;
•  children with CI failure if reimplantation in the same 
ear is contraindicated;
•  children  with  multiple  disabilities  (case-by-case 
evaluation).
Both simultaneous and sequential procedures are admit-
ted, although the simultaneous procedure is recommend-
ed. in the case of sequential bilateral implantation, a short 
delay between surgeries is recommended.
8. CI recipient registry
A registry to collect data on Ci recipients in Ci centres in 
italy is recommended to pool data, which should be made 
available for epidemiological studies.
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